There has been significant debate regarding the safety of achieving very low LDL-C levels, including a potential negative impact on cognitive function. The current ACC/AHA guidelines (circa 2013) suggest decreasing the statin dose in patients with two consecutive LDL-C levels below 40 mg/dL based on expert opinion. The lack of evidence has been a major challenge for clinicians and it is unclear whether medication doses should be reduced in high-risk patients who may benefit from very low LDL-C levels. A recently published meta-analysis sought to address this clinical dilemma.
Podcast Case: Very Low LDL Case
Guest Authors: Apryl Anderson, PharmD and Dave Dixon, PharmD, BCPS, BCACP, CLS, CDE
Music by Good Talk
Eosinophils Take the Wheel in Steering Steroid Therapy for COPD Exacerbations
SDOH Matters Too! Patient and Care Team Perspectives on Screening for SDOH
Treating Depression and Anxiety: Dosing, Pharmacogenetics, and Our Learners
Complex Patient Case 4: Diabetes, CKD, and Psoriasis
Can Losing Weight Using Semaglutide Prevent a Heart Attack, Ack, Ack, Ack, Ack?
Prescription for Savings: The Clinical and Economic Impact of Pharmacist-Led Hypertension Management in the U.S.
Heartburn Headache: Cumulative PPI Use and Dementia Risk
Does Size Matter? The Surprising Impact of Cuff Size on Blood Pressure Readings
Defining the Role of Semaglutide in Obese Patients with Heart Failure with Preserved Ejection Fraction
Do Statins “REPRIEVE” People Living with HIV from CV Events?
Top Ten Things Every Clinician Should Know About the RSV Vaccines
Complex Patient Case 3: Treatment Resistant Hypertension
Should We Be Good SPORTs About Supplements for Cholesterol?
Is Telehealth the Hidden (Hyper)Link to Controlling Blood Pressure?
Personalized Pharmacotherapy for Hypertension: Examining Intra-patient Variability
Over-the-Counter Hearing Aids – Where Do They Fit?
Road to Recovery: Pharmacist-Delivered Comprehensive Medication Management in an SUD Clinic
Gender Affirming Care - Finding the Resources You Need
Water Wars: Dueling Diuretics - Chlorthalidone vs. Hydrochlorothiazide for Cardiovascular Event Reduction
Beyond Statins: Approaches to Lipid Lowering in 2023
Create your
podcast in
minutes
It is Free
The Relaxback UK Show
Good Nurse Bad Nurse
On Call With Dr. Anselm Anyoha
The Doctor’s Farmacy with Mark Hyman, M.D.
The Peter Attia Drive